Antibiotic-resistant bacterial infections kill millions of people worldwide each year, but a Canadian researcher has uncovered how bacteria naturally fight off viruses in ways that could revolutionize treatment. Karen Maxwell, a biochemistry professor at the University of Toronto's Temerty Faculty of Medicine, has been named a 2026 Peter Gilgan Canada Gairdner Momentum Award laureate for her groundbreaking work on bacterial immune systems and how they could be harnessed to create next-generation precision therapies .

What Makes Maxwell's Discovery So Important for Fighting Antibiotic Resistance?

Maxwell's research reveals that bacteria possess sophisticated molecular defense mechanisms against viruses called bacteriophages, or phages. Her lab discovered and characterized multiple new bacterial immune systems, showing how bacteria deploy these defenses when infected. One of her key findings is that some bacteria produce small chemical compounds that act as a form of "chemical immunity," blocking viral replication before it can spread .

What makes this particularly exciting for medicine is that Maxwell's discoveries have provided a foundation for designing precise, next-generation phage-based therapies. These therapies could offer an alternative to traditional antibiotics for treating infections that have become resistant to conventional drugs. The research transforms how scientists understand the evolutionary arms race between bacteria and the viruses that infect them, revealing new pathways for therapeutic intervention .

How Do Bacteria Actually Defend Themselves Against Viruses?

Maxwell's team uncovered that bacterial immunity is shaped by genes carried on mobile pieces of DNA, including viral DNA left behind in bacterial genomes. These dormant viral elements can actively protect their hosts by detecting invading viruses and triggering rapid immune responses. The research demonstrates how bacteria develop counter-defenses to overcome viral attacks, creating a dynamic biological system that scientists are only beginning to understand .

The implications of this work extend beyond treating infections. Maxwell's discoveries have also played a role in understanding CRISPR-Cas9, the revolutionary gene-editing technology that scientists adapted from a natural bacterial defense mechanism. Her team contributed to discovering the first inhibitors of CRISPR-Cas9 systems, which researchers are now using to develop more precise gene-editing tools for biotechnology and healthcare applications .

Steps to Understanding How Phage Therapy Could Work

• Bacterial Immunity Recognition: Scientists identify how bacteria naturally recognize and respond to viral invaders using chemical signals and genetic memory stored in their DNA.
• Phage Selection and Design: Researchers select or engineer specific bacteriophages that can target antibiotic-resistant bacteria while avoiding harm to beneficial bacteria in the body.
• Precision Delivery: Phage therapies are designed to be highly specific, attacking only the target bacteria rather than broadly damaging the microbiome like some antibiotics do.
• Clinical Testing: Candidate phage therapies undergo rigorous testing to ensure safety and effectiveness before being used to treat patients with resistant infections.

Maxwell's work has earned her significant recognition in the scientific community. The Canada Gairdner Awards, established in 1957, are Canada's most prestigious prizes for health sciences research. Nearly a quarter of Gairdner recipients have subsequently received Nobel Prizes, making this award a strong indicator of transformative research .

"Maxwell is a leading figure in redefining our understanding of phages and phage-bacteria interactions. Her findings significantly expand the landscape of microbial immunity and spark new lines of exploration in biotechnology, medicine, and phage-based therapy," said Sylvain Moineau, a professor of microbiology at Université Laval and curator of the Félix d'Hérelle Reference Center for Bacterial Viruses.

Sylvain Moineau, Professor of Microbiology at Université Laval

Beyond treating human infections, Maxwell's discoveries have practical applications in food production. In cheese and yogurt manufacturing, phage infections can spoil entire batches of starter cultures, causing significant economic losses for producers. Understanding how to control phage infection in these industrial applications could protect food safety and reduce waste .

Maxwell emphasizes that her research reveals connections between bacterial and human immunity. "Learning how bacterial immunity works can reveal really important information about how human immunity works as well," she explained. This cross-disciplinary insight suggests that understanding bacterial defense mechanisms may ultimately help researchers develop better treatments for human immune system disorders .

Maxwell

The recognition comes as antibiotic resistance continues to pose a growing global health threat. With bacteria increasingly developing resistance to conventional antibiotics, phage-based therapies represent a promising alternative that could help preserve the effectiveness of existing drugs while offering new treatment options for patients with resistant infections. Maxwell's work provides the scientific foundation for turning this potential into clinical reality.